Skip to main content
Premium Trial:

Request an Annual Quote

Insightful Science Acquires Data Science Company Omiq

NEW YORK – Insightful Science said on Thursday that it has acquired Omiq, a data science company offering software solutions for high-dimensional flow cytometry and quantitative multiomics data.

Financial and other terms of the transaction were not disclosed.

Omiq’s principal product is OMIQ, a cloud-based cytometry analysis platform that allows researchers to identify drug or therapeutic interactions in lab samples by tracking biomarkers, Insightful said.

Based in San Diego, Insightful provides data analysis, visualization, and bioinformatics products for life science research. The company said the addition of OMIQ "expands [its] offerings in flow cytometry software solutions."

After the acquisition, OMIQ will continue as a standalone product but will connect with Insightful's other products, the company added.

"We are thrilled to welcome Omiq into the company to help advance our vision to build the world's largest scientific platform to support researchers through every step of the R&D process," Thomas Swalla, Insightful's CEO, said in a statement.

In ​​March 2021, Insightful inked a deal to acquire scientific software company Dotmatics for an undisclosed amount.

Insightful is privately held by Insight Partners, a global venture capital and private equity firm.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.